Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cytokinetics
company
Funding Round
Post-IPO Debt
Money Raised
$ 450M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Royalty Pharma | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jul 21, 2021 | Post-IPO Equity | $ 316.25M | Detail | |
| Jul 16, 2020 | Post-IPO Equity | $ 201.30M | Detail | |
| Jun 19, 2012 | Post-IPO Equity | $ 42.50M | Detail | |
| Mar 31, 2003 | Series E | $ 40M | Vulcan | Detail |
| Feb 20, 2014 | Post-IPO Equity | $ 37.40M | Detail | |
| Jan 18, 2006 | Post-IPO Equity | $ 33M | Federated Kaufmann Fund,Red Abbey Venture Partners | Detail |
| Apr 19, 2011 | Post-IPO Equity | $ 20M | Deepfield | Detail |
| Apr 29, 2004 | IPO | $ 89.70M | Detail |
